Lansoprazole Capsule, Delayed Release
Product Images NDC 43598-161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 43598-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
Lansoprazole Delayed-Release Capsules USP, 15 mg, acid reducer by Dr. Reddy's Laboratories Inc. The label identifies it as a 14-capsule package for a one 14-day course of treatment. It includes Drug Facts with uses, warnings, directions, and inactive ingredients. The label shows the NDC 43598-161-52 and states the product is made in India.*
FDA Label Image

Container (Container)

Container (Container)
Lansoprazole Delayed-Release Capsules USP, 15 mg, acid reducer capsules in a blister pack with label from Dr. Reddy's Laboratories Inc. The carton displays 14 capsules, a 14-day treatment course. The label provides directions for use, storage instructions, warnings, and contact information for questions, emphasizing it is an over-the-counter product for frequent heartburn relief.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.